Medicenna Therapeutics Corp. (MDNA.TO)
CAD 1.75
(-2.23%)
CAD 1.75
(-2.23%)
| Breakdown | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|
| Revenue | - | - | - | - | - | - |
| Cost of Revenue | 5000.00 | 5000.00 | 38 Thousand | 40 Thousand | 7893.00 | 6818.00 |
| Gross Profit | -5000.00 | -5000.00 | -38 Thousand | -40 Thousand | -7893.00 | -6818.00 |
| Operating Expenses | 19.66 Million | 16.3 Million | 22.47 Million | 17.39 Million | 8.24 Million | 4.72 Million |
| Selling, General and Administrative Expenses | 7.87 Million | 6.99 Million | 7.72 Million | 6.48 Million | 2.49 Million | 2.2 Million |
| Research and Development Expenses | 11.78 Million | 9.3 Million | 14.71 Million | 10.87 Million | 5.86 Million | 3.01 Million |
| Other Expenses | - | 5000.00 | 37 Thousand | 40 Thousand | -117.47 Thousand | -499.37 Thousand |
| Cost and Expenses | 19.66 Million | 16.3 Million | 22.47 Million | 17.39 Million | 8.24 Million | 4.72 Million |
| Operating Income | -19.66 Million | -21.64 Million | -22.3 Million | -17.18 Million | -8.2 Million | -4.72 Million |
| Interest Expense | - | - | 69 Thousand | - | - | - |
| Income Tax Expense | - | -11.59 Million | 69 Thousand | -106 Thousand | 32.27 Thousand | 19.25 Thousand |
| Earnings before Tax | -25.46 Million | -10.04 Million | -22.57 Million | -17.28 Million | -8.27 Million | -4.7 Million |
| Net Income | -25.46 Million | 1.54 Million | -22.64 Million | -17.18 Million | -8.3 Million | -4.7 Million |
| Earnings Per Share Basic | -0.37 | 0.02 | -0.42 | -0.35 | -0.26 | -0.18 |
| Earnings Per Share Diluted | -0.37 | 0.02 | -0.42 | -0.35 | -0.26 | -0.18 |
| Weighted Average Shares Outstanding | 69.63 Million | 64.73 Million | 54.28 Million | 49.66 Million | 31.89 Million | 25.67 Million |
| Weighted Average Shares Outstanding (Diluted) | 69.63 Million | 64.73 Million | 54.28 Million | 49.66 Million | 31.89 Million | 25.67 Million |
| Gross Margin | - | - | - | - | - | - |
| EBIT Margin | - | - | - | - | - | - |
| Profit Margin | - | - | - | - | - | - |
| EBITDA | -18.67 Million | -16.29 Million | -22.53 Million | -17.24 Million | -8.26 Million | -4.7 Million |
| Earnings Before Tax Margin | - | - | - | - | - | - |
| Breakdown | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 | 2023 Q2 | 2023 Q1 |
|---|---|---|---|---|---|---|
| Revenue | 5000.00 | - | - | - | - | - |
| Cost of Revenue | 5000.00 | 1000.00 | 5000.00 | 2000.00 | 1000.00 | 1000.00 |
| Gross Profit | - | -1000.00 | -5000.00 | -2000.00 | -1000.00 | -1000.00 |
| Operating Expenses | 4.03 Million | 4 Million | 18.66 Million | 4.77 Million | 5.43 Million | 4.45 Million |
| Selling, General and Administrative Expenses | 1.25 Million | 2.13 Million | - | 1.78 Million | 2.3 Million | 1.64 Million |
| Research and Development Expenses | 2.78 Million | 1.86 Million | - | 2.99 Million | 3.13 Million | 2.81 Million |
| Other Expenses | 18 Thousand | - | - | - | - | - |
| Cost and Expenses | 4.04 Million | 4 Million | 18.67 Million | 4.77 Million | 5.43 Million | 4.45 Million |
| Operating Income | -4.04 Million | -4 Million | -18.67 Million | -4.77 Million | -6.8 Million | -4459.00 |
| Interest Expense | - | - | - | - | - | - |
| Income Tax Expense | 3.6 Million | - | - | 41.58 Thousand | -1.71 Million | -1.59 Million |
| Earnings before Tax | -3.63 Million | -13.9 Million | -25.46 Million | -4.97 Million | -3.72 Million | -2.86 Million |
| Net Income | -3.63 Million | -13.9 Million | -25.46 Million | -4.97 Million | -3.72 Million | -2.86 Million |
| Earnings Per Share Basic | -0.05 | -0.20 | - | -0.07 | -0.05 | -0.04 |
| Earnings Per Share Diluted | -0.05 | -0.20 | - | -0.07 | -0.05 | -0.04 |
| Weighted Average Shares Outstanding | 73.62 Million | 69.63 Million | 69.63 Million | 69.63 Million | 69.63 Million | 69.63 Million |
| Weighted Average Shares Outstanding (Diluted) | 73.62 Million | 69.63 Million | 69.63 Million | 69.63 Million | 69.63 Million | 69.63 Million |
| Gross Margin | - | - | - | - | - | - |
| EBIT Margin | -807.00 | - | - | - | - | - |
| Profit Margin | -727.40 | - | - | - | - | - |
| EBITDA | -4.03 Million | -4 Million | - | -4.77 Million | -6.8 Million | -5.7 Million |
| Earnings Before Tax Margin | -808.00 | - | - | - | - | - |
300722
AZGFF
002524
SAVA
600368
6093